Questcor Pharmaceuticals Inc (QCOR)

93.60
1.52 1.65
NASDAQ : Health Care
Prev Close 92.08
Open 92.93
Day Low/High 92.17 / 94.42
52 Wk Low/High 47.71 / 97.80
Volume 3.18M
Avg Volume 1.57M
Exchange NASDAQ
Shares Outstanding 61.45M
Market Cap 5.75B
EPS 4.99
P/E Ratio 16.10
Div & Yield 1.20 (1.30%)

Latest News

Greenberg on the Stock Market: Why Investigations No Longer Matter

Greenberg on the Stock Market: Why Investigations No Longer Matter

I can't remember the last time a company got more than a slap on the wrist.

Retrophin CEO Under Fire for Twitter Faux Pas

Retrophin CEO Under Fire for Twitter Faux Pas

Retropin employees were using alias Twitter accounts -- two of which affected the persona of gangster rappers -- to promote Retrophin and pitch short-sale recommendations of other stocks to followers.

Questcor Pharmaceuticals (QCOR) Hits New Lifetime High Today

Questcor Pharmaceuticals (QCOR) Hits New Lifetime High Today

Trade-Ideas LLC identified Questcor Pharmaceuticals (QCOR) as a new lifetime high candidate

Trade-Ideas: Questcor Pharmaceuticals (QCOR) Is Today's Post-Market Leader Stock

Trade-Ideas: Questcor Pharmaceuticals (QCOR) Is Today's Post-Market Leader Stock

Trade-Ideas LLC identified Questcor Pharmaceuticals (QCOR) as a post-market leader candidate

Why a 5% to 10% market correction may be in the cards

Why a 5% to 10% market correction may be in the cards

Mid-term election years historically are bumpy ones for stocks.

Today's Post-Market Laggard: Questcor Pharmaceuticals (QCOR)

Today's Post-Market Laggard: Questcor Pharmaceuticals (QCOR)

Trade-Ideas LLC identified Questcor Pharmaceuticals (QCOR) as a post-market laggard candidate

Today's Stocks Driving Success For The Health Care Sector

Today's Stocks Driving Success For The Health Care Sector

TheStreet highlights 3 stocks pushing the health care sector higher today.

Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Announce Early Termination Of HSR Act Waiting Period

Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Announce Early Termination Of HSR Act Waiting Period

Mallinckrodt plc (NYSE: MNK), and Questcor Pharmaceuticals, Inc.

New Lifetime High Today: Questcor Pharmaceuticals (QCOR)

New Lifetime High Today: Questcor Pharmaceuticals (QCOR)

Trade-Ideas LLC identified Questcor Pharmaceuticals (QCOR) as a new lifetime high candidate

Questcor Pharmaceuticals Inc (QCOR): Today's Featured Drugs Winner

Questcor Pharmaceuticals Inc (QCOR): Today's Featured Drugs Winner

Questcor Pharmaceuticals was a winner within the drugs industry, rising $1.09 (1.3%) to $84.24 on light volume

Questcor CEO's Daughter Granted Huge Pay Raise

Questcor CEO's Daughter Granted Huge Pay Raise

Her salary jumps to more than $1 million in 2013 from $300,000 in 2012, according to Questcor disclosure.

INVESTOR ALERT – Questcor Pharmaceuticals, Inc.: The Law Offices Of Vincent Wong Investigates The Sale Of Questcor Pharmaceuticals, Inc. To Mallinckrodt

INVESTOR ALERT – Questcor Pharmaceuticals, Inc.: The Law Offices Of Vincent Wong Investigates The Sale Of Questcor Pharmaceuticals, Inc. To Mallinckrodt

The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Questcor Pharmaceuticals Inc.

Questcor Pharmaceuticals Inc (QCOR): Today's Featured Drugs Laggard

Questcor Pharmaceuticals Inc (QCOR): Today's Featured Drugs Laggard

Questcor Pharmaceuticals was a leading decliner within the drugs industry, falling $2.45 (-3.0%) to $79.05 on average volume

Questcor Pharmaceuticals Inc. (QCOR): Today's Featured Drugs Laggard

Questcor Pharmaceuticals Inc. (QCOR): Today's Featured Drugs Laggard

Questcor Pharmaceuticals was a leading decliner within the drugs industry, falling $1.51 (-1.9%) to $76.95 on light volume

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation Of Questcor Pharmaceuticals, Inc. In Connection With The Sale Of The Company

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation Of Questcor Pharmaceuticals, Inc. In Connection With The Sale Of The Company

Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Questcor Pharmaceuticals, Inc.

Jim Cramer: In the Abstract, the Shorts May Be Right

Jim Cramer: In the Abstract, the Shorts May Be Right

But in the real world they're wrong, as the Questcor buyout demonstrates.

Jim Cramer's Mad Dash: QCOR MNK

Jim Cramer's Mad Dash: QCOR MNK

Investors don't know what to make of Mallinckrodt's planned acquisition of Questcor, Cramer says.

Perilous Reversal Watch: Questcor Pharmaceuticals (QCOR)

Perilous Reversal Watch: Questcor Pharmaceuticals (QCOR)

Trade-Ideas LLC identified Questcor Pharmaceuticals (QCOR) as a "perilous reversal" (up big yesterday but down big today) candidate

Jim Cramer's Top Stock Picks: FSLR NFLX AMZN TSLA PCLN

Jim Cramer's Top Stock Picks: FSLR NFLX AMZN TSLA PCLN

Priceline is Cramer's favorite in the over $500 a share category while First Solar is best of breed and very inexpensive.

QUESTCOR INVESTOR ALERT: Faruqi & Faruqi, LLP Announces The Investigation Of Questcor Pharmaceuticals Inc. (QCOR) Over The Proposed Sale Of The Company To Mallinckrodt Plc (MNK)

QUESTCOR INVESTOR ALERT: Faruqi & Faruqi, LLP Announces The Investigation Of Questcor Pharmaceuticals Inc. (QCOR) Over The Proposed Sale Of The Company To Mallinckrodt Plc (MNK)

Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Questcor Pharmaceuticals Inc.

Jim Cramer's 'Mad Money' Recap: Where's the Rally?

Jim Cramer's 'Mad Money' Recap: Where's the Rally?

Cramer says the economy may be getting better but the markets sure aren't showing it.

SHAREHOLDER ALERT: Brower Piven Announces The Investigation Of Questcor Pharmaceuticals Inc. Over The Proposed Sale Of The Company To Mallinckrodt Plc

SHAREHOLDER ALERT: Brower Piven Announces The Investigation Of Questcor Pharmaceuticals Inc. Over The Proposed Sale Of The Company To Mallinckrodt Plc

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty to current shareholders of Questcor Pharmaceuticals Inc.

U.S. Stocks Get Crushed on Valuation Concerns in Technology, Biotechs

U.S. Stocks Get Crushed on Valuation Concerns in Technology, Biotechs

U.S. markets tumble Monday, extending Friday's selloff amid concerns of over-inflated valuations in technology and biotech as investors turn toward value stocks.

2 Big Stocks the Crowd Is Talking About

2 Big Stocks the Crowd Is Talking About

Here's how to trade some of the most active names on the market today.

Questcor Pharma Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Acquisition By Mallinckrodt

Questcor Pharma Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Acquisition By Mallinckrodt

Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Questcor...

Mallinckrodt to Buy Questcor: 5 Deals That Blew Up the Short-Sellers

Mallinckrodt to Buy Questcor: 5 Deals That Blew Up the Short-Sellers

Questcor Pharmaceuticals has been a controversial stock for years, as short selling research firm Citron Research raised concerns about the company's Acthar gel, which is marketed for multiple sclerosis and other autoimmune and inflammatory disorders.